BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36920857)

  • 1. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary.
    Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
    Expert Rev Hematol; 2023 Mar; 16(sup1):129-134. PubMed ID: 36920857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
    Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
    Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science.
    Byams VR; Baker JR; Bailey C; Connell NT; Creary MS; Curtis RG; Dinno A; Guelcher CJ; Kim M; Kulkarni R; Lattimore S; Norris KL; Ramirez L; Skinner MW; Symington S; Tobase P; Vázquez E; Warren BB; Wheat E; Buckner TW
    Expert Rev Hematol; 2023 Mar; 16(sup1):87-106. PubMed ID: 36920863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.
    Tran DQ; Benson CC; Boice JA; Chitlur M; Dunn AL; Escobar MA; Gupta K; Johnsen JM; Jorgenson J; Martin SD; Martin S; Meeks SL; Narvaez AA; Quon DV; Reding MT; Reiss UM; Savage B; Schafer K; Steiner B; Thornburg C; Volland LM; von Drygalski A
    Expert Rev Hematol; 2023 Mar; 16(sup1):19-37. PubMed ID: 36920859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.
    Nugent D; Acharya SS; Baumann KJ; Bedrosian C; Bialas R; Brown K; Corzo D; Haidar A; Hayward CPM; Marks P; Menegatti M; Miller ME; Nammacher K; Palla R; Peltier S; Pruthi RK; Recht M; Sørensen B; Tarantino M; Wolberg AS; Shapiro AD
    Expert Rev Hematol; 2023 Mar; 16(sup1):55-70. PubMed ID: 36920862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding.
    Ragni MV; Young G; Batsuli G; Bisson E; Carpenter SL; Croteau SE; Cuker A; Curtis RG; Denne M; Ewenstein B; Federizo A; Frick N; Funkhouser K; George LA; Hoots WK; Jobe SM; Krava E; Langmead CJ; Lewis RJ; López J; Malec L; Mann Z; Miles ME; Neely E; Neufeld EJ; Pierce GF; Pipe SW; Pitler LR; Raffini L; Schnur KM; Shavit JA
    Expert Rev Hematol; 2023 Mar; 16(sup1):107-127. PubMed ID: 36920855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate.
    Baldwin MK; Ahmadzia HK; Bartlett DL; Bensen-Kennedy D; Desai V; Haley KM; Herman-Hilker SL; Kilgore AM; Kulkarni R; Lavin M; Luckey S; Matteson KA; Paulyson-Nuñez K; Philipp CS; Ragosta S; Rosen K; Rotellini D; Weyand AC
    Expert Rev Hematol; 2023 Mar; 16(sup1):71-86. PubMed ID: 36920864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building the blueprint: Formulating a community-generated national plan for future research in inherited bleeding disorders.
    Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
    Haemophilia; 2022 Sep; 28(5):760-768. PubMed ID: 35700441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Hemophilia Foundation's State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders.
    Valentino LA; Witkop ML; Santaella ME; DiMichele D; Recht M
    Expert Rev Hematol; 2023 Mar; 16(sup1):1-5. PubMed ID: 36920858
    [No Abstract]   [Full Text] [Related]  

  • 10. Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.
    Pacheco LD; Saade GR; James AH
    Obstet Gynecol; 2023 Mar; 141(3):493-504. PubMed ID: 36800851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries.
    Chuansumrit A; Ruchutrakul T; Sirachainan N; Kitpoka P; Panuwannakorn M; Panburana P; Suwannuraks M; Sri-Udomporn N; Kijkunasathian C; Jaovisidha S; Utamakul C; Natesirinilkul R; Pongtanakul B; Traivaree C; Komvilaisak P; Suwantaroj E; Sosothikul D; Angchaisuksiri P; Rojnuckarin P
    Expert Rev Hematol; 2023; 16(12):1063-1076. PubMed ID: 38100503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How I approach bleeding in hospitalized patients.
    Bannow BS; Konkle BA
    Blood; 2023 Aug; 142(9):761-768. PubMed ID: 36652635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of inherited bleeding disorders in pediatrics.
    El-Bostany EA; Omer N; Salama EE; El-Ghoroury EA; Al-Jaouni SK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):771-5. PubMed ID: 19002043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
    Nichols TC; Dillow AM; Franck HW; Merricks EP; Raymer RA; Bellinger DA; Arruda VR; High KA
    ILAR J; 2009; 50(2):144-67. PubMed ID: 19293459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive care for hemophilia and other inherited bleeding disorders.
    Page D
    Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited Bleeding Disorders in the Obstetric Patient.
    Bannow BS; Konkle BA
    Transfus Med Rev; 2018 Oct; 32(4):237-243. PubMed ID: 30097224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis in hemophilia and von Willebrand disease.
    Swystun LL; James PD
    Blood Rev; 2017 Jan; 31(1):47-56. PubMed ID: 27596108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.